Eads & Heald Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hubbell
HUBB
|
+$982K |
| 2 |
Accenture
ACN
|
+$562K |
| 3 |
Helmerich & Payne
HP
|
+$456K |
| 4 |
Elevance Health
ELV
|
+$338K |
| 5 |
Toll Brothers
TOL
|
+$205K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$533K |
| 2 |
NVIDIA
NVDA
|
+$488K |
| 3 |
UnitedHealth
UNH
|
+$430K |
| 4 |
Amphenol
APH
|
+$401K |
| 5 |
D.R. Horton
DHI
|
+$371K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.17% |
| 2 | Industrials | 15.56% |
| 3 | Healthcare | 13.31% |
| 4 | Consumer Discretionary | 11.98% |
| 5 | Consumer Staples | 10.06% |
Similar funds
Eads & Heald Wealth Management's Q2 2025 Portfolio in Review
As of Q2 2025, Eads & Heald Wealth Management held 143 positions worth $202M, up 2.8% from $197M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Eads & Heald Wealth Management withdrew a net $6.16M in Q2 2025, closing 9 positions and reducing 95 holdings. Its most notable exit was Gilead Sciences, an estimated $308K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Eads & Heald Wealth Management opened a new position in Hubbell worth $1.08M.
- Eads & Heald Wealth Management's largest Q2 2025 buy was Hubbell: 2,650 shares worth $1.08M.
- Eads & Heald Wealth Management added most to Accenture in Q2 2025, an estimated $562K increase.
- Eads & Heald Wealth Management's biggest Q2 2025 reduction was Netflix, cutting an estimated $533K.
- Eads & Heald Wealth Management fully exited Gilead Sciences in Q2 2025, selling an estimated $308K.
- Eads & Heald Wealth Management's ten largest holdings make up 19% of its $202M portfolio in Q2 2025.
- Eads & Heald Wealth Management opened 5 new positions and closed 9 in Q2 2025.
- Eads & Heald Wealth Management's portfolio value rose 2.8% quarter-over-quarter to $202M.
Based on Eads & Heald Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.